Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Na ïve Patients with Compensated Cirrhosis
In the original article, there is an error in Fig. 1.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Cirrhosis | Drugs & Pharmacology